Posts filtered by tags: Pfizer[x]


 

Australia live news updates: Pfizer provisionally approved for five to 11-year-olds; Victoria records 980 new Covid cases and seven deaths

Omicron cases continue to climb in Sydney as thousands of people protest for ‘freedom’ in MelbourneAs Sydney comes back to life, scars of lockdown linger in the westAustralia and Omicron: how and when will the pandemic actually end?Get our free news app; get our morning email briefingHunt is asked whether states, like Queensland, will hold off opening state borders until at least 80% of kids aged five to 11 are vaccinated given today’s announcement.Hunt:There is no reason for that. The Doherty m...
Tags: Health, Science, Australia, Australia news, Infectious Diseases, Australian politics, Queensland, New South Wales, Sydney, Vaccines and immunisation, Victoria, Pfizer, Melbourne, Canberra, Northern Territory, Doherty


Australia live news updates: Pfizer provisionally approved for five to 11-year-olds; Bandt staffer tests positive for Covid

Omicron cases continue to climb in Sydney as thousands of people protest for ‘freedom’ in MelbourneAs Sydney comes back to life, scars of lockdown linger in the westAustralia and Omicron: how and when will the pandemic actually end?Get our free news app; get our morning email briefingHunt is asked whether states, like Queensland, will hold off opening state borders until at least 80% of kids aged five to 11 are vaccinated given today’s announcement.Hunt:There is no reason for that. The Doherty m...
Tags: Health, Science, Australia, Australia news, Infectious Diseases, Australian politics, Queensland, New South Wales, Sydney, Vaccines and immunisation, Victoria, Pfizer, Melbourne, Canberra, Northern Territory, Doherty


Booster Doses are Powerful, May Fight Omicron, Researchers Find

Last week researchers at Northwestern University calculated that one week after a Covid-19 booster shot, median antibody levels were 23 times higher than before the shot. This Thursday the Times of London reported that another study found similar results: Booster jabs "massively" strengthen the body's defences against Covid, according to key results that have raised hopes of strong protection from the Omicron variant. A third dose not only increased antibody levels thirtyfold, but roughly tri...
Tags: Tech, Fda, Pfizer, Business Insider, Northwestern University, Hill, Johnson Johnson, Faust, The Hill, Times of London, Scott Gottlieb, Moderna, Omicron, Albert Bourla, Bourla, COVID


Pfizer said it expects to have more data by end of year on whether COVID-19 vaccine can be administered to children under 5

Carlo Allegri/Reuters Pfizer CEO Albert Bourla on Friday said there will be more data on children under five receiving a COVID-19 vaccine by the end of the year. Pfizer has begun pediatric vaccine trials. Moderna and Johnson & Johnson are also planning to conduct trials.  Pfizer's announcement comes as the new Omicron variant begins to spread in the United States. Pfizer CEO Albert Bourla on Friday said the company expects to know more about the effectiveness of its vaccines in children u...
Tags: Health, Science, News, US, Trends, United States, Pfizer, Vaccines, Anthony Fauci, Johnson Johnson, Fauci, Moderna, Stéphane Bancel, Omicron, Albert Bourla, Bourla


Covid vaccine protests in Melbourne as Kerry Chant warns of ‘uptick’ in Omicron cases

Greg Hunt says TGA and Atagi to decide on Pfizer vaccines for children by the end of the yearThe Australian government says Covid vaccines could soon be rolled out for children as young as five as Victoria reported nine deaths and the NSW health minister, Kerry Chant, warned of “an uptick” in Omicron cases in metropolitan Sydney.The federal health minister, Greg Hunt, said on Saturday that the regulators – the Therapeutic Goods Administration and the Australian Technical Advisory Group on Immuni...
Tags: Australia news, Australian politics, Queensland, New South Wales, Sydney, Victoria, Pfizer, Melbourne, Greg Hunt, South Australia, Therapeutic Goods Administration, Coronavirus, Kerry Chant, Australian Technical Advisory Group


The labor shortage is reportedly creating longer COVID-19 vaccine wait times at CVS and Walgreens

High demand for booster shots and COVID-19 vaccines are leading to long lines at CVS and Walgreens, The Wall Street Journal reports.Joe Raedle/Getty Images Patients in some states are waiting weeks to get a COVID vaccine at CVS and Walgreens, per WSJ. The Omicron variant and new vaccine rules for kids is creating higher demand for jabs. Retail pharmacies in states like Connecticut and Kentucky are facing staff shortages. As demand for vaccines and booster shots increases, retail pharmacies ar...
Tags: New York, News, California, Cdc, Kentucky, White House, US, Trends, Walmart, Walgreens, Connecticut, Healthcare, Delta, Retail, World Health Organization, Pfizer


What we do — and don't — know about the Omicron variant

Hello, Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and this week in healthcare news:We spoke to experts of all kinds to figure out what we know so far about the new Omicron COVID-19 variant;Major hospital systems told us how technology will change the future of patient care — and what's overhyped;We dug into the new ways powerful drug-industry middlemen are driving up costs. If you're new to this newsletter, sign up here. Comments, tips? Email me at lrosenbau...
Tags: US, Trends, Walmart, Walgreens, South Africa, Philadelphia, Fda, Pfizer, HILARY, Shelby, Penn Medicine, Mikael Dolsten, Andrew Dunn, Mohana Ravindranath, Leah Read, Hilary Brueck


Pfizer and Moderna give best overall boost - UK trial

Researchers say there are signs the boosters would still offer protection against new variant Omicron.
Tags: UK, News, Pfizer, Moderna


Covid: Pfizer and Moderna jabs give best overall boost, UK trial finds

Researchers also say there are signs the boosters would still offer protection against new variant Omicron.
Tags: UK, News, Pfizer, Moderna


Vaccines are the key. They're also making some people very rich.

The US government has put billions of dollars into developing and producing Covid-19 vaccines, but it doesn't own them. Taxpayers are now paying Pfizer and Moderna billions for the vaccines.
Tags: US, Cnn, Pfizer, Moderna


How to choose which booster shot is right for you, between Pfizer and Moderna

Vials of the Moderna (R) and Pfizer (L) COVID-19 vaccines.Hazem Bader/AFP via Getty Images Most people who've gotten booster shots in the US have stuck with the same brand of vaccine they had initially. But, it's also fine to switch it up. Some early studies suggest that Moderna's vaccine is slightly stronger than Pfizer's. "To be honest, I'm not sure there's really a big difference between those two," one expert said. Now that free booster shots are being offered to a...
Tags: Science, News, US, Trends, Public Health, Pfizer, Anthony Fauci, Johnson Johnson, J J, Johns Hopkins University, R, International Vaccine Access Center, L, Moderna, William Moss, Hilary Brueck


COVID Patents at the Federal Circuit (Moderna Loses)

by Dennis Crouch Moderna Therapeutics v. Arbutus BioPharma (Fed. Cir. 2021) (20-1184 Decision) (20-2329 Decision) Arbutus owns several patents related to a lipid-based delivery system for nucleic-acid-based treatments.  U.S. Patent 8,058,069 and 9,364,435 are the two at issue here. The claims are directed to the creation of a “acid-lipid particle” that includes some RNA along with lipids to stabilize the sequence, including particular percentages of cationic lipids, non-cationic lipids, and conj...
Tags: Law, Pfizer, Patent, Federal Circuit, IPR, Moderna, Protiva, Arbutus, Federal Circuit Moderna, Dennis Crouch Moderna Therapeutics, Arbutus BioPharma Fed


‘Boost Day’ drive launches to mark one year since COVID-19 vaccine approval in the UK

The UK is marking one year since it became the first country in the world to approve Pfizer's COVID-19 vaccine with a "Boost Day" call.
Tags: Health, UK, Pfizer, COVID


UK Covid live: PM says people should not cancel Christmas events after highest cases since 17 July recorded

Latest updates: Boris Johnson says ‘no need’ to cancel Christmas events as UK reports 53,945 daily coronavirus casesDining out in UK at lowest level since May amid Omicron fearsAvoid ‘snogging under mistletoe’ this Christmas, says UK ministerEngland’s biggest theatres make mask-wearing mandatoryScientists find possible trigger for AstraZeneca jab blood clotsCoronavirus – latest global updatesJeremy Corbyn posted a tweet this morning promoting a virtual Stop the War fundraiser this Christmas, not...
Tags: Politics, UK, France, UK News, Infectious Diseases, Northern Ireland, Astrazeneca, Boris Johnson, Vaccines and immunisation, Pfizer, Cabinet Office, Corbyn, Emmanuel Macron, George Freeman, Angela Rayner, Coronavirus


86 Stillbirths in Waterloo Region over a time frame that should only have seen about 12

Chatham Kent MPP Rick Nicholls recently asked Ontario's Health Minister Christine Elliot what testing was done to ensure the safety of pregnant women and their unborn children who've been vaccinated with the Covid-19 shots.  He cited statistics showing that the Waterloo Region had reported 86 stillbirths from January to July of this year, compared to normal rates of just one or two per month seen in previous years.  One key difference between 2021 and previous years of course is that all the sti...
Tags: Travel, Pfizer, Ontario, Chatham, Elliot, Christine Elliot, Gordie Canuk, Waterloo Region, Rick Nicholls


Pfizer CEO Albert Bourla: My wife's vaccine death is fake news

In an exclusive interview, Albert Bourla hits out at the "rubbish" that has been published about him.
Tags: Health, Pfizer, Albert Bourla


A study on NBA players and staff found vaccinated people with breakthrough infections may be less likely to spread COVID-19 to others

Mohammed, 18, receives his first Pfizer vaccine on June 6, 2021 in Stanmore, Greater London.Hollie Adams/Getty Images The study was conducted in partnership with the NBA. It examined nearly 20,000 viral samples from the league's occupational health program. It found vaccinated people cleared their infections an average of two days faster. A new study of NBA players, staff, and household members provides yet more evidence that fully vaccinated people who get a breakthrough case of COVID-19...
Tags: Science, Cdc, Study, US, Trends, Research, Harvard University, Healthcare, Delta, Nba, Vaccinations, Pfizer, National Basketball Association, Anthony Fauci, Charles Davis, Mohammed


The 2 factors that will determine if Omicron is a true threat, according to Pfizer's top scientist

Hello,Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:Pfizer's top scientist told Insider how the company plans to approach the Omicron variant;Omicron didn't necessarily emerge in South Africa, the country was just the first to identify it;An FDA advisory panel narrowly backed Merck's COVID-19 antiviral pill molnupiravir.  If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tw...
Tags: Texas, Massachusetts, Africa, Trends, Merck, South Africa, Delta, Who, Fda, Pfizer, Anthony Fauci, Cape Town South Africa, Mikael Dolsten, Wall Street Journal Supreme Court, Rodger Bosch, Leah Read


Pfizer to Seek FDA Approval of Boosters for Teens Ages 16-17

Title: Pfizer to Seek FDA Approval of Boosters for Teens Ages 16-17Category: Health NewsCreated: 11/30/2021 12:00:00 AMLast Editorial Review: 11/30/2021 12:00:00 AM
Tags: Fda, Pfizer


An FDA expert panel narrowly supports the first COVID-19 pill but suggests restrictions on its use driven by safety concerns

Molnupiravir is an experimental oral antiviral developed by Merck and Ridgeback Biotherapeutics that could treat COVID-19Merck The first COVID-19 pill is closer to reality, as an FDA panel voted in favor on Tuesday.  But the group also recommended limiting its use to people at high risk of severe disease.  Merck's drug reduced hospitalizations and deaths by 30% compared to a placebo.  A pill to treat COVID-19 just got closer to reality, as the Food and Drug Administration's expert pan...
Tags: US, Trends, Merck, Food And Drug Administration, Miami, Fda, Pfizer, Morgan Stanley, Yale University, University of California Riverside, Cowen, David Eastman, University of Utah Health, SVB Leerink, Ridgeback Biotherapeutics, Molnupiravir


Pfizer's top scientist Mikael Dolsten tells us the 2 factors that will determine if Omicron is a true threat and shares Pfizer's worst-case-scenario plan

Mikael Dolsten, Pfizer's chief scientific officer.Pfizer Omicron could require new vaccines if two factors are met, Pfizer's top scientist told Insider. The new variant would need to outcompete Delta globally and reduce protection from the current vaccine. Pfizer's Mikael Dolsten shared the plan to have an Omicron-specific shot ready by March 2022.  Mikael Dolsten, Pfizer's chief scientific officer, told Insider that the drugmaker is already preparing for the worst-case scenar...
Tags: US, Trends, South Africa, Delta, Pfizer, Johnson Johnson, Mikael Dolsten, Andrew Dunn, Omicron, Mikael Dolsten Pfizer, Moderna Novavax, Dolsten, Paxlovid, Pfizer Omicron, Omicron Dolsten, Delta Dolsten


Pfizer chief scientist interview: Omicron's threat to vaccines

Pfizer's chief scientist Mikael Dolsten highlighted two elements that will determine how the Omicron variant shapes the future of the pandemic. #omicron #chiefscientistinterview #pfizer #mikaeldolsten
Tags: Pfizer, Mikael Dolsten


Fourth Stimulus Check: Should You Expect Another Relief Payment?

cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p0").init({"mcp":"cbs","width":"100%","height":"100%","video":"5728445","autoplay":false,"accessKey":"5VD6Eyd6djewbCmNwBFnsJj17YAvGRwl","accessControl":{"preview":false},"pInstance":"p0","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId":"sc_va","marketingCloudId":"[email protected]","trackingServer":"cbsdigitalmedia.hb.omtrdc.net","customTrack...
Tags: Florida, New York, Texas, News, Minnesota, Maryland, Pua, Congress, California, Washington, Senate, Massachusetts, Elizabeth Warren, West Virginia, Bank Of America, Joe Biden


BioNTech CEO Says Vaccine Likely to Protect Against Severe COVID From Omicron

By Ludwig Burger and Patricia WeissFRANKFURT (Reuters) -BioNTech and Pfizer's established COVID-19 vaccine will likely offer strong protection...
Tags: Pfizer, COVID


Pfizer to Seek FDA Approval of Boosters for Teens Ages 16-17

By Robert Preidt and Robin Foster, HealthDay ReporterTUESDAY, Nov. 30, 2021 (HealthDay News) -- Pfizer Inc. is expected to seek approval this week...
Tags: Fda, Pfizer, Robin Foster, Robert Preidt, HealthDay News Pfizer Inc


Pfizer CEO is 'very confident' the company's oral COVID-19 pill will be effective against the new variant

Pfizer CEO Albert BourlaCrystal Cox/Insider Pfizer's CEO told CNBC his company's oral COVID-19 treatment will work against the Omicron variant. "I'm very very confident that this drug works for all known mutations, including the Omicron one," he said. Pfizer said the antiviral pill led to a 89% reduction in hospitalizations and deaths in a study. Pfizer CEO Albert Bourla said he believes his company's COVID-19 oral treatment will work in patients diagnosed with the Omicron var...
Tags: News, Trends, Merck, South Africa, Healthcare, Food And Drug Administration, Fda, Pfizer, Cnbc, Reuters Pfizer, Andrew Dunn, Albert Bourla, Bourla, Allana Akhtar, Coronavirus, COVID


Oil heads for biggest monthly loss since March 2020, after Moderna boss questions vaccine effectiveness against Omicron

Oil wells at near Moorpark, California.David McNew/Getty Images Oil prices resumed their fall as investors shunned crude futures over concerns about vaccine effectiveness against Omicron. Moderna's CEO told the FT there was "no world" in which current vaccines would offer the same cover as for Delta. Brent crude is heading for its biggest monthly loss since the onset of the pandemic in March 2020. Oil prices slid Tuesday, erasing all of the previous day's gains, after comments by Mode...
Tags: Russia, US, Trends, Opec, Joe Biden, Pfizer, Cnbc, Cmc, Jpmorgan, Hansen, Hewson, Michael Hewson, Scott Gottlieb, Moderna, Amanda Cooper, Stéphane Bancel


Moderna's CEO doubtful the current crop of COVID-19 vaccines will be as effective against Omicron variant as they have been against Delta

Moderna CEO Stéphane BancelERIC PIERMONT/AFP via Getty Images Moderna's CEO said current COVID-19 vaccines won't be as effective against Omicron as they have been against Delta. Stéphane Bancel told FT "all the scientists I've talked to . . . are like 'this is not going to be good.'" Omicron was first identified by the World Health Organization as a "variant of concern" on November 24. Moderna CEO Stéphane Bancel said it's unlikely that current COVID-19 vaccines will b...
Tags: US, Trends, South Africa, Delta, Who, World Health Organization, Pfizer, Financial Times, Cnbc, Afp, World Health Organization WHO, Piermont, Moderna, Stéphane Bancel, Omicron, Albert Bourla


Pfizer expected to seek additional FDA authorization for boosters

Pfizer is expected to seek authorization from the US Food and Drug Administration for its vaccine booster shot for those who are ages 16 and 17, a source familiar with the plan told CNN on Monday.
Tags: News, Cnn, Stories, Fda, Pfizer, US Food and Drug Administration


Pfizer expected to seek FDA authorization for boosters for those ages 16 and 17

Pfizer is expected to seek authorization from the US Food and Drug Administration for its vaccine booster shot for those who are ages 16 and 17, a source familiar with the plan told CNN on Monday.
Tags: Cnn, Fda, Pfizer, US Food and Drug Administration